Marta Nyakas
5PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 22, 2023
Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma.Caroline Robert, Matteo S Carlino, Catriona McNeil
|Feb 13, 2023
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial.Paolo Antonio Ascierto, Evan J Lipson, Reinhard Dummer
|Sep 16, 2022
Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti-PD-1-Resistant Advanced Melanoma.Alexander N Shoushtari, Anthony J Olszanski, Marta Nyakas
|Jan 10, 2020
Soluble AXL as a marker of disease progression and survival in melanoma.Karine Flem-Karlsen, Marta Nyakas, Inger Nina Farstad
|Mar 02, 2019
Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma.M Nyakas, E Aamdal, K D Jacobsen
Pageof 1
Frequent Collaborators
2 joint publications
Jean-Jacques Grob
2 joint publications
Georgina V Long
2 joint publications
James Larkin
1 joint publications
Omid Hamid
1 joint publications
Alexander N Shoushtari
1 joint publications
Anthony J Olszanski
1 joint publications
Thomas J Hornyak
1 joint publications
Jedd D Wolchok
1 joint publications
Victor Levitsky
1 joint publications
Thomas B Hansen
